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ABSTRACT 
 
Background: Epidemiological data show that the incidence of heart failure after 
myocardial infarction is about 20%. The incidence of heart failure after acute 
myocardial infarction is also known to increase post-infarct mortality. The 
incidence of heart failure is related to the remodelling process after acute 
myocardial infarction. The acute remodelling process after acute myocardial 
infarction involves a mechanical mechanism in which there is a change in left 
ventricular geometry as an adaptive response to the incidence of infarction and 
then results in increased left ventricular wall stress. Increased left ventricular 
wall stress can be assessed by measuring global longitudinal strain (GLS) using 
echocardiography. On the other hand, mechanical overload in the myocardium 
is known to increase sST2 levels. The relationship between increased levels of 
sST2 and left ventricular GLS in patients with acute myocardial infarction has 
never been studied before. 
Methods: An analytic observational study with a cross-sectional design 
conducted from July to September 2018 at Dr Sardjito Hospital. Patients 
diagnosed with acute myocardial infarction and fulfilling the inclusion and 
exclusion criteria were included in the study. Measurement of sST2 levels and 
echocardiographic examination was performed on the first day after admission. 
Correlation test analysis was conducted to determine the relationship between 
sST2 levels and left ventricular GLS. 
Results: There were 72 subjects, with 62 STEMI subjects and 10 NSTEMI 
subjects. The mean level of sST2 in this study was 4,252 ± 198 pg / mL. 
Measurement of the left ventricular function obtained a mean ejection fraction of 
47 ± 9%, LVIDd 45.79 ± 6.2 mm, and GLS values of -9.3 ± 3.3%. Correlation 
test using Spearman test showed that there was no correlation between 
increased sST2 levels and decreased GLS values in patients with acute 
myocardial infarction (r = -0.133; p = 0.344). 
Conclusion: Increased sST2 levels were not correlated with decreased GLS 
values in patients with acute myocardial infarction. 
 
Keywords: soluble suppression of tumorigenicity 2; global longitudinal strain; 
acute myocardial infarct; post-infarctremodelling 
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INTISARI 
 
Latar Belakang: Data epidemiologi menyatakan angka kejadian gagal jantung pasca 
infark miokard sebesar 20%. Kejadian gagal jantung pasca infark miokard akut juga 
diketahui meningkatkan mortalitas pasca infark. Kejadian gagal jantung berkaitan 
dengan proses remodeling pasca infark miokard akut. Proses remodeling akut pasca 
infark miokard akut melibatkan mekanisme mekanik dimana terjadi perubahan 
geometri ventrikel kiri sebagai respon adaptif terhadap kejadian infark dan kemudian 
mengakibatkan peningkatan stres dinding ventrikel kiri. Peningkatan stress dinding 
ventrikel kiri dapat dinilai dengan pengukuran global longitudinal strain (GLS) 
menggunakan ekokardiografi. Di sisi lain, overload mekanik pada miokardium diketahui 
menyebabkan peningkatan kadar sST2. Hubungan peningkatan kadar sST2 dengan 
nilai GLS ventrikel kiri pada pasien infark miokard akut belum pernah diteliti 
sebelumnya. 
Metode Penelitian: Penelitian ini adalah studi observasional analitik dengan desain 
potong lintang yang dilakukan sejak Juli – September 2018 di RSUP Dr. Sardjito. 
Pasien yang terdiagnosis infark miokard akut dan memenuhi kriteria inklusi dan 
eksklusi dimasukkan ke dalam penelitian. Pengukuran kadar sST2 dan pemeriksaan 
ekokardiografi dilakukan pada hari pertama setelah admisi. Analisis uji korelasi 
dilakukan untuk mengetahui hubungan kadar sST2 dengan GLS ventrikel kiri. 
Hasil: Didapatkan sampel sebanyak 72 subjek, dengan 62 subjek STEMI dan 10 
subjek NSTEMI. Rerata kadar sST2 pada penelitian ini didapatkan 4.252 ± 198 pg/mL. 
Pengukuran fungsi ventrikel kiri didapatkan rerata fraksi ejeksi 47±9%, LVIDd 
45,79±6,2 mm, dan nilai GLS sebesar -9,3 ± 3,3%. Uji korelasi menggunakan uji 
Spearman didapatkan tidak ada hubungan antara peningkatan kadar sST2 dengan 
penurunan nilai GLS pada pasien infark miokard akut (r=-0,133; p=0,344). 
Simpulan: Peningkatan kadar sST2 tidak berhubungan dengan penurunan nilai GLS 
pada pasien infark miokard akut. 
 
 
INTRODUCTION 
 
Acute myocardial infarction 
(AMI) is defined as cardiac cell death 
due to prolonged ischemia as a result 
of an acute imbalance between oxygen 
supply and oxygen demand.1 
Epidemiological data show the 
incidence of acute myocardial infarction 
with ST-segment elevation (STEMI) per 
year reaches 695,000 new cases with a 
mortality rate of around 14%, while the 
incidence of heart failure after 
myocardial infarction is around 20%. 
The incidence of heart failure after 
acute myocardial infarction is known to 
increase post-infarct mortality and 
morbidity.1 
The left ventricular remodelling 
process is defined as molecular, 
cellular and interstitial changes in the 
myocardium due to injury to the 
myocardium, such as in acute 
myocardial infarction, which manifests 
as changes in size, mass, geometry 
and left ventricular  function. Changes 
in left ventricular geometry due to the 
remodelling  process  after   myocardial 
 
infarction include thinning of the 
ventricular wall and dilatation of the left 
ventricle.2 This change in geometry 
results in increased ventricular wall 
stress as compensation. Continuous 
remodelling process can cause 
symptoms of heart failure.3 Global 
longitudinal strain (GLS) is known to be 
a predictor of remodelling events after 
acute myocardial infarction, GLS> -10% 
to -15% is known as a marker of high 
risk of ventricular remodelling after 
acute myocardial infarction.4 
Suppression of Tumorigenicity 2 
(ST2) is a member of the interleukin (IL) 
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-1 receptor protein family with two 
transmembrane or cellular (ST2L) and 
soluble (sST2) main isoforms that can 
circulate in the serum. Biomarker sST2 
is a protein similar to the interleukin (IL) 
1 receptor, which levels increase in 
serum when the heart experiences 
mechanical stress.5 Experiments with 
increasing cardiac burden in vivo 
studies have been shown to cause 
elevations in both ST2 and soluble ST2 
trans-membrane levels. In another in 
vivo study, the induction of myocardial 
infarction was shown to cause 
increased levels of sST2.6 Early studies 
in patients who experienced AMI 
proved that sST2 levels increased 
during infarct presentation and 
correlated linearly with serum creatinine 
kinase and inversely correlated with left 
ventricular function.7 SST2 levels were 
analysed in more than 800 patients with 
acute myocardial infarction with ST-
segment elevation (STEMI), it was 
found that sST2 levels at presentation 
correlated with mortality at treatment 
and 30 days after treatment. However, 
there have been no studies that have 
examined the association of sST2 
levels with the initial phase remodelling 
parameters after AMI.  
 
METHODS 
 
This study was an analytic 
observational study with a cross-
sectional design. The sample of this 
study was AMI patients who were 
treated at Dr. Sardjito Hospital 
Yogyakarta between July and 
September 2018.The inclusion criteria 
in this study were patients with a 
diagnosis of AMI with an age range of 
30-75 years with the onset of less than 
72 hours. Exclusion criteria include: 1) 
Patients with a history of heart failure, 
2) Patients with chronic renal failure, 3) 
Patients with hepatic cirrhosis, 4) 
Patients with concomitant pneumonia 
and/or acute exacerbations of chronic 
obstructive pulmonary disease during 
hospitalization, 5) Patients with sepsis 
during hospitalization, 6) Patients with 
malignancy, 7) Patients with aortic 
stenosis, 8) Patients with hypertrophic 
cardiomyopathy or left ventricle outflow 
tract (LVOT) obstruction, 9) The quality 
of echocardiographic images is not 
good enough for strain analysis. 
We assessed patients with AMI 
who entered through the emergency 
room for their suitability with the study 
criteria. Demographic data, clinical 
profiles, electrocardiogram images, and 
laboratories were collected and 
recorded in the case report form. 
Demographic data are gender, age, 
smoking status, history of diabetes 
mellitus, hypertension, and chronic 
concomitant diseases namely chronic 
kidney disease, chronic heart failure, 
liver cirrhosis, chronic obstructive 
pulmonary disease and malignancy. 
Clinical profile data includes systolic 
blood pressure, diastolic blood 
pressure, heart rate frequency and 
Killip class values. Electrocardiogram 
images were obtained with 12 lead 
electrocardiogram devices, right leads 
(V2R, V3R and V4R) and posterior 
leads (V7, V8 and V9) and assessed 
during admission and hospital 
treatment. Routine laboratory data 
includes (1) routine blood tests namely 
hemoglobin, leukocyte numbers, 
leukocyte count, platelet counts, (2) 
examination of lipid profiles namely: 
triglyceride concentrations, HDL 
cholesterol, total cholesterol and LDL  
cholesterol, (3) examination of kidney 
function: urea and creatinine (4) 
glucose examination when and (5) 
examination of cardiac enzymes, 
namely: CK-MB and HsTrop I (if serially 
needed). Blood specimens for sST2 
measurement were takenwithin the first 
24 hoursthen processed for serum 
isolation. The serum is inserted in a 
microtube and stored in a freezer with a 
temperature of -80⁰C until sST2 
quantification. Transthoracic 
echocardiography was also performed 
within the first 24 hours with VIVID S6 
(General Electric, American) or HD 15 
(Philip, Netherlands). If an intervention 
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is performed or new myocardial 
infarction happens between taking 
blood specimens with transthoracic 
echocardiography examination, the 
sample will be excluded. We measured 
GLS using speckle-tracking method, 
which is carried out using the standard 
EchoPAC program by two observers 
who are blind to clinical data. 
Longitudinal strain analysis was carried 
out on the apical 4-chamber window, 
apical 2-chamber and apical 3-
chamber. At each inspection window, 
the program will determine the border 
of the myocardium automatically. If it is 
felt that the automatically determined 
myocardium limit is not suitable, then 
the myocardium border will be 
determined manually. The GLS value is 
determined by taking the average value 
of the longitudinal strain from the three 
apical windows.Soluble ST2 level was 
quantified by quantitative sandwich 
enzyme immunoasay technique using 
R&D systems ELISA kit (Abington, 
United Kingdom). 
Statistical analysis used the 
version 20 Statistical Package for 
Social Sciences (SPSS) software for 
the Windows operating system. Basic 
characteristics data on numerical scale 
variables will be presented in the form 
of average values and standard 
deviations. Data with categorical 
variables will be presented as a 
percentage.  Data from independent 
variables and dependent variables are 
assessed whether they are normally 
distributed or not.Hypothesis testing of 
the correlation between independent 
variables (sST2) and the dependent 
variable (left ventricular strain) will be 
analysed using Pearson if the data 
distribution is normal or Spearman if the 
distribution is not normal. Statistically 
significant results when p <0.05. 
 
RESULTS 
 
This study was conducted from 
July 2018 to September 2018 in Dr. 
Sardjito Hospital. During this period 
there was a total population of 87 AMI 
patients. Fifteen subjects were 
excluded, five subjects due to heart 
failure, two subjects due to a history of 
chronic kidney failure, two subjects due 
to chronic pulmonary obstructive 
disease, two subjects due to sepsis and 
four subjects because 
echocardiographic data could not be 
analysed. So the total sample was 72 
subjects with baseline characteristics 
are as shown in table 1. 
Sixty-two (86.1%) subjects were 
diagnosed with STEMI. Fifty-nine (82%) 
subjects came with Killip I, and 50 
(69.4%) subjects were revascularized. 
Echocardiographic data showed: mean 
ejection fraction of 47 ± 9%, mean 
LVIDd of 45.79 ± 6.2 mm; mean 
LVEDV was 78 ± 29 ml, mean LVESV 
was 42 ± 19 ml. Mean sST2 level of 
4,252 ± 198 pg / mL, while mean GLS 
of -9.3 ± 3, 3%.In the analysis of the 
correlation analysis of sST2 levels with 
GLS, we find a negative correlation with 
r = -0.133, p=0.344 (figure 1).  
 
DISCUSSION 
 
 The mean sST2 levels in this 
study were obtained at 4,252 ± 198 pg / 
mL with the highest value of 4,525 pg / 
mL and the lowest value of 3,793 pg / 
mL. The level of sST2 in this study 
increased when compared to normal 
values in healthy individuals. The 
normal value of sST2 in healthy 
individuals is known to be 6.7-20.4 pg / 
mL. In a study in STEMI, sST2 levels 
increase beyond normal values from 6-
18 hours since the onset of infarction.8 
The study conducted by Weinberg in 69 
AMI patient subjects it was found that 
sST2 levels increased on the first day 
after AMI with an average of sST2 
levels of 3.8 ± 0.4 ng / mL with a 
maximum value of 0.32 ng / mL and a 
maximum value of 17.42 ng / mL.6 The 
GLS value in this study obtained an 
average of -9.3 ± 3.3% with a maximum 
value of -16.6% and a minimum value 
of -3.1%. 
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Table 1. Basic characteristics 
Parameters Value 
Gender 
Male; n (%) 
 
56 (77.8) 
Age (year); mean ± SD 58.71 ± 13.00 
Diagnosis 
STEMI; n (%) 
NSTEMI; n (%) 
Onset (hour); mean ± SD 
 
62 (86.1) 
10 (13.9) 
9.4 ± 8.0 
Killip class 
Killip I; n (%) 
Killip II; n (%) 
Killip III; n (%) 
Killip IV; n (%) 
 
59 (82.0) 
8 (11.0) 
3 (4.2) 
2 (2.8) 
Revascularisation 
Revascularized; n (%) 
 
50 (69.4) 
Risk Factor 
Diabetes Mellitus; n (%) 
Hypertension; n (%) 
Smoker; n (%) 
Dyslipidemia; n (%) 
 
20 (28) 
43 (60) 
33 (46) 
30 (43) 
Therapy 
Aspilet; n (%) 
P2Y12Inhibitor; n (%) 
Clopidogrel 
Ticagrelor 
Anti-remodelling; n (%) 
ACE-I + bisoprolol 
ACE-I 
ARB + bisoprolol 
ARB 
Bisoprolol 
No therapy 
Statin; n (%) 
 
72 (100) 
 
52 (72) 
20 (28) 
 
33 (46) 
20 (28) 
2 (3) 
3 (4) 
3 (4) 
11 (15) 
72 (100) 
Echocardiography Parameter 
Ejection fraction(%); mean ± SD 
LVIDd (mm); mean ± SD 
LVEDV (ml); mean ± SD 
LVESV(ml); mean ± SD 
GLS (%); mean ± SD 
 
47 ± 9 
46 ± 6 
78 ± 29 
42 ± 19 
-9.3 ± 3.3 
Hs Trop I ; mean ± SD 14.128 ± 16.683 
Soluble ST2 (pg/mL); mean ± SD 4,252 ±198 
LVIDd: left ventricular inner diameter diastolic; LVEDV: left ventricular end diastolic volume; LVESV: left 
ventricular end systolic volume; GLS: global longitudinal strain; Hs Trop I: high sensitivity troponin I 
 
 
The normal value of GLS 
according to the American Society of 
Echocardiography and the European 
Association of Cardiovascular Imaging 
is -20% with a range between -17.3% to 
-21.5%.9 So the GLS value obtained in 
this study is lower than the normal 
value in healthy individuals.The result is 
consistent with various studies of GLS 
in the AMI population. The study 
conducted by Antoniet et al. in the 
subject population of acute myocardial 
infarction with the entire subject of 341 
patients with acute myocardial 
infarction performed by primary PCI, 
the mean value of GLS -13.7 ± 3.3%, 
with echocardiographic examination 
performed at 48 hours from 
admission.10 
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Figure 1. Scatter-plot correlation between sST2 and GLS in patients with acute myocardial infarction (r = -
0.113, p = 0.344) 
 
The study conducted by 
Aniyathodiyil et al. in 50 subjects with 
STEMI who were revascularized with 
primary PCI and performed 
echocardiography before the primary 
PCI action, the mean of GLS was -
12.41 ± 2.95%.12 Decreased GLS 
values as found in this study and 
previous studies illustrate an increase 
in left ventricular strains after AMI. The 
mean value of GLS obtained in this 
study was lower than the GLS value in 
the previous study, possibly due to 
echocardiography in this study carried 
out at 24 hours of treatment, regardless 
of the revascularisation performed. 
From the correlation test 
conducted on sST2 levels and GLS 
values in patients with AMI, no 
relationship was found between the two 
variables. The incidence of AMI will 
begin a series of remodelling processes 
in the left ventricle that initially are 
adaptive responses to decreased left 
ventricular function due to myocardial 
infarction. One of the early phase 
remodelling processes is the 
occurrence of mechanical changes in 
contraction of the left ventricle due to 
shifting of myocytes after infarction, 
which then increases the stress of the 
left ventricular wall and causes 
deformation of the myocardium and an 
increase in left ventricular strains 
measured by decreased GLS. The 
initial phase remodelling process also 
occurs at the cellular level where the 
death of heart muscle cells will trigger 
the inflammatory process as part of the 
process of healing the left ventricle after 
acute myocardial infarction. One of the 
cells involved is fibroblast cells, which 
will be activated and proliferate and in 
the later phase of the remodelling 
process will form fibrosis tissue.2 
Soluble ST2 is known to be produced 
by cardiomyocytes and is a feed 
receptor from IL-33.  
Whereas cardiac fibroblast cells 
are known to produce IL-33 under the 
- 
- 
- 
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conditions of mechanical strains, in 
which IL-33 plays a role in inhibiting the 
occurrence of myocardial hypertrophy 
and fibrosis when binding to the 
transmembrane ST2 receptor. When 
sST2 levels in serum are high, sST2 
will be a competitor receptor of the ST2 
receptor found in transmembrane. The 
bond between IL-33 and sST2 will 
eliminate the protective effect on the 
myocardium.13,14  
So there is no correlation 
between the increase in sST2 levels 
and the decrease in GLS in this study 
whether due to an increase in sST2 
levels more due to myocardial fibrosis 
compared to the increase in mechanical 
stress after acute myocardial 
infarction.15 The statement was 
supported by previous studies which 
concluded that sST2 levels were 
positively correlated with infarction 
volume index (r = 0.26; p = 0.023)16 and 
good infarct area at 1 week post AMI (r 
= 0, 41; p <0.001) and 6 months post 
AMI (r = 0.50; p <0.001).17 However, 
this study did not examine fibrosis 
markers to determine whether sST2 
levels were correlated with fibrosis in 
post-AMI myocardial. 
Until now, there have been no 
studies that have examined changes in 
sST2 levels over time so that the 
pattern of changes in sST2 levels after 
AMI has not been known over time. 
Research by Weinberg et al. in 69 
subjects with AMI patients it was found 
that sST2 levels increased on the first 
day after AMI.6 The research conducted 
by Sabatine et al. in the STEMI 
population, measuring sST2 levels at 
the time of admission of patients in the 
emergency department as baseline 
measurements and at the time of 
angiography (average 4 days after 
admission), the results of sST2 levels at 
angiography were lower than baseline, 
but remain higher than normal values.14 
Research by Weir et al. measured 
sST2 levels in the AMI population three 
times, first at baseline, i.e. 7-14 days 
after AMI onset, second at 12 weeks 
after baseline and third at 24 weeks 
after baseline. The level of sST2 was 
found to remain high at 24 weeks 
measurement but decreased 
significantly compared to baseline 
levels, with the most decrease 
occurring between baseline levels and 
12 weeks evaluation.16  
These studies show that sST2 
levels will increase since the onset of 
AMI onset and remain high for weeks 
after AMI. Remodelling parameters in 
these studies were measured in the 
further phase of remodelling, which 
averaged six months after AMI. From 
these studies, it is known that sST2 
levels are correlated with the incidence 
of advanced phase remodelling after 
AMI. While in this study the 
measurement of sST2 levels and 
measurement of acute phase 
remodelling parameters, namely GLS 
parameters, were cross-sectional in the 
first 24 hours after AMI.  
In this study, taking blood 
specimens for measuring sST2 levels 
and echocardiographic examinations to 
assess GLS was also not done at the 
same time. The absence of correlation 
between the increase in sST2 value 
and the incidence of acute phase post-
AMI remodelling which is characterised 
by a decrease in GLS in this study, 
probably because the post-AMI 
remodelling process is a series of 
processes starting from the onset of 
AMI and can last for months after 
AMI.18 So further research might be 
needed to examine the relationship of 
sST2 levels with the longitudinal stages 
of the post-AMI remodelling process. 
The post-AMIremodelling 
process is an ongoing process that 
starts after an AMI event and can last 
for months after the AMI event.18 
Whereas this research was conducted 
in a cross-sectional design, which only 
took data at one time only at 24 hours 
post-AMI so that it became a limitation 
of this study because it could not 
describe the remodelling process as a 
whole. Another limitation of this study is 
that this study did not assess fibrosis 
markers,so it was not known whether 
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the post-AMI fibrosis process was 
correlated with an increase in sST2 
levels in patients with AMI and this 
might be investigated in future studies. 
 
CONCLUSION 
Increased sST2 levels were not 
correlated with a decrease in left 
ventricular GLS in patients with acute 
myocardial infarction. 
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